Global COPD and Asthma Devices Market - Industry Analysis 2015-2019

Market outlook of the global COPD and asthma devices market

Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles. The rising availability of portable drug delivery devices is a significant factor that is responsible for this market’s modest growth rate of nearly 4% by 2019.

In this market research report, Technavio’s analysts estimate factors like the augmented use of home healthcare devices to impel market growth during the forecast period. The development of portable inhalers and nebulizers that provide aerosol therapy to patients help in reducing the duration of hospital stays. Since these devices are reliable and comfortable, their increasing usage will drive the prospects for growth in this market during the forecast period.

Product-type segmentation of the COPD and asthma devices market

• Metered dose inhalers (MDI)
• Drug powder inhalers (DPI)
• Soft mist inhalers
• Jet nebulizers
• Ultrasonic nebulizers

The DPI segment is expected to dominate over all the other segments due to its ability to effectively treat conditions like COPD, bronchitis, and asthma. DPI involves the release of a dry medicinal powder in place of a liquid mist and is expected to account for more than 47% of the total market share by 2019.

Geographical segmentation of the COPD and asthma devices market

• APAC
• EMEA
• Americas

Geographically, the Americas are expected to dominate the global market for COPD and medical devices followed by the EMEA and the APAC regions. Technological advancements and favorable Medicare reimbursements in the Americas are responsible for this region’s high market share of approximately 48% during the forecast period.

Competitive landscape and key vendors

This market is in its growth stage and contains numerous global and regional vendors that offer a variety of nebulizers in the market. As the market is highly competitive, vendors use innovative marketing strategies like online marketing tools to provide customized nebulizers for patients. This helps vendors to gain a competitive edge over their rivals during the predicted period of 2014-2019.

Key vendors in this market are -

• Consort Medical
• Gerresheimer
• NYPRO
• Philips Healthcare
• RPC BRAMLAGE

Other prominent vendors in this market are Aerogen, Airon, Allied Healthcare Products, AstraZeneca, Boehringer Ingelheim, Briggs Healthcare, Cardinal Health, Clement Clarke International, DeVilbiss Healthcare, Drive Medical Design and Manufacturing, GlaxoSmithKline, Heyer Medical, Invacare, Omron Healthcare, PARI Medical, Salter Labs, Smart inhaler, Sunovion Pharmaceuticals, Teleflex, and Vortran Medical.

Key questions answered in the report include

• What will the market size and the growth rate be in 2019?
• What are the key factors driving the global COPD and asthma devices market?
• What are the key market trends impacting the growth of the global COPD and asthma devices market?
• What are the challenges to market growth?
• Who are the key vendors in the global COPD and asthma devices market?
• What are the market opportunities and threats faced by the vendors in the global COPD and asthma devices market?
• Trending factors influencing the market shares of APAC, EMEA, and the Americas?
• What are the key outcomes of the five forces analysis of the global COPD and asthma devices market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

• Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018
• Global Respiratory Devices Market 2014-2018